Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease

Liu, K.Y., Senn, S. and Howard, R. (2025) Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease. Alzheimer's & Dementia, 21 (2). e14457. ISSN 1552-5260

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Liu, K.Y.
  • Senn, S.
  • Howard, R.
Copyright, Publisher and Additional Information:

© 2025 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Alzheimer's disease; clinically meaningful; minimal clinically important difference; responder analysis; trial; within‐individual change
Dates:
  • Published: February 2025
  • Published (online): 27 January 2025
  • Accepted: 13 November 2024
  • Submitted: 29 August 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 04 Feb 2025 14:39
Last Modified: 12 Mar 2025 17:01
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1002/alz.14457
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics